← Back to Search

Ultrasound

Active Ultrasound Device for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by ZetrOZ, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are you between 35 and 80 years of age (inclusive)?
Can you speak, read, and write in English?
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first week (start of study) to 24 weeks (end of study)
Awards & highlights

Study Summary

This study will measure the 24-week pain relief from long-duration ultrasound on the symptoms of knee arthritis pain.

Eligible Conditions
  • Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first week (start of study) to 24 weeks (end of study)
This trial's timeline: 3 weeks for screening, Varies for treatment, and first week (start of study) to 24 weeks (end of study) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pain Units on a Numeric Rating Scale (NRS)
Secondary outcome measures
Function
Range of motion
Strengthen

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active Ultrasound DeviceActive Control1 Intervention
Active treatment
Group II: Sham Ultrasound DevicePlacebo Group1 Intervention
No ultrasound treatment

Find a Location

Who is running the clinical trial?

ZetrOZ, Inc.Lead Sponsor
15 Previous Clinical Trials
1,165 Total Patients Enrolled
7 Trials studying Osteoarthritis
732 Patients Enrolled for Osteoarthritis
Ralph Ortiz, MPH, DOStudy DirectorMedical Pain Consultants

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Mar 2025